ES2103828T3 - Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica. - Google Patents

Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica.

Info

Publication number
ES2103828T3
ES2103828T3 ES91917981T ES91917981T ES2103828T3 ES 2103828 T3 ES2103828 T3 ES 2103828T3 ES 91917981 T ES91917981 T ES 91917981T ES 91917981 T ES91917981 T ES 91917981T ES 2103828 T3 ES2103828 T3 ES 2103828T3
Authority
ES
Spain
Prior art keywords
viral particles
rotaviric
disease
vaccine against
assembled viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917981T
Other languages
English (en)
Inventor
Mark J Redmond
Mohammed Khalid Ijaz
Michael D Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Application granted granted Critical
Publication of ES2103828T3 publication Critical patent/ES2103828T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12323—Virus like particles [VLP]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTAN PARTICULAS VIRALES UNIDAS DERIVADAS DE PROTEINAS DE ROTAVIRUS. LAS PARTICULAS UNIDAS INCLUYEN LA PROTEINA CAPSIDA INTERIOR, VP6, JUNTO CON UNA O LAS DOS PROTEINAS CAPSIDAS EXTERIORES, VP4 Y VP7. ESTAS UNIONES SE PUEDEN UTILIZAR PARA COMPOSICIONES DE VACUNAS PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES ROTAVIRALES.
ES91917981T 1990-10-25 1991-10-24 Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica. Expired - Lifetime ES2103828T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/603,133 US5298244A (en) 1990-10-25 1990-10-25 Assembled viral particles and their use in a vaccine to rotaviral disease

Publications (1)

Publication Number Publication Date
ES2103828T3 true ES2103828T3 (es) 1997-10-01

Family

ID=24414222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917981T Expired - Lifetime ES2103828T3 (es) 1990-10-25 1991-10-24 Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica.

Country Status (11)

Country Link
US (1) US5298244A (es)
EP (1) EP0652957B1 (es)
JP (1) JPH06504190A (es)
AT (1) ATE152768T1 (es)
AU (1) AU659416B2 (es)
CA (1) CA2094916A1 (es)
DE (1) DE69126043T2 (es)
DK (1) DK0652957T3 (es)
ES (1) ES2103828T3 (es)
GR (1) GR3024173T3 (es)
WO (1) WO1992007941A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5431899A (en) * 1991-02-04 1995-07-11 University Of Saskatchewan Rotavirus VP6 as a diagnostic and targeting agent
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US6165993A (en) * 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
WO1996001651A1 (en) 1994-07-11 1996-01-25 The Government Of The United States Of America, Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
US5959093A (en) 1996-06-28 1999-09-28 The Ohio State University Research Foundation Bovine rotavirus genes
AU2004203804B2 (en) * 1998-10-30 2007-01-25 Children's Hospital Medical Center Rotavirus subunit vaccine
US6589529B1 (en) 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
DE60130987T2 (de) * 2000-06-23 2008-07-24 Wyeth Holdings Corp. Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps)
WO2002036172A2 (en) * 2000-11-03 2002-05-10 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
WO2004042001A2 (en) * 2002-05-17 2004-05-21 Emory University Virus-like particles, methods of preparation, and immonogenic compositions
US9045727B2 (en) 2002-05-17 2015-06-02 Emory University Virus-like particles, methods of preparation, and immunogenic compositions
WO2006007555A2 (en) * 2004-07-01 2006-01-19 Children's Medical Center Corporation ¨ Rotavirus antigens
WO2009148964A2 (en) * 2008-05-29 2009-12-10 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression and assembly of human group c rotavirus-like particles and uses thereof
FI122520B (fi) * 2010-10-15 2012-03-15 Vesna Blazevic Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena
US9446117B2 (en) 2012-02-14 2016-09-20 Merial, Inc. Rotavirus subunit vaccines and methods of making and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
CA1319101C (en) * 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

Also Published As

Publication number Publication date
DE69126043D1 (de) 1997-06-12
GR3024173T3 (en) 1997-10-31
ATE152768T1 (de) 1997-05-15
EP0652957B1 (en) 1997-05-07
EP0652957A1 (en) 1995-05-17
JPH06504190A (ja) 1994-05-19
CA2094916A1 (en) 1992-04-26
WO1992007941A1 (en) 1992-05-14
AU8718791A (en) 1992-05-26
DK0652957T3 (da) 1997-10-27
DE69126043T2 (de) 1997-09-18
US5298244A (en) 1994-03-29
AU659416B2 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
ES2103828T3 (es) Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica.
FI963424A (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
ATE83374T1 (de) Neue galenische form von fenofibrat.
MY107843A (en) Anti-viral compounds.
ES2081102T5 (es) Vacuna para el herpes simple compuesta por glicoproteina gd del hsv y lipido a de monofosforilo 3-desacilado.
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
FR2683531B1 (fr) Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
MX9102110A (es) Muteina de factor de necrosis tumoral humano o una sal farmaceuticamente aceptable de la misma,procedimiento para su preparacion y composicion farmaceutica que la contiene
UY25262A1 (es) 5-derivados sustituidos del ácido micofenolico
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
ES2141750T3 (es) Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno.
IT8019071A0 (it) Plicazione terapeutica. derivati del nor-tropano, loro procedimento di preparazione e loro ap
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
DK0939648T3 (da) Rotavirusvaccineformuleringer
ITMI913092A0 (it) Vaccino di poxvirus ricombinate del virus del morbillo
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
NO911065L (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
PE20000630A1 (es) Prenda de uso desechable con mejor adaptacion al cuerpo
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
DK0385909T3 (da) Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 652957

Country of ref document: ES